ADTN is a dopamine receptor agonist. References: Pinheiro T, Otrocka M, Seashore-Ludlow B, Rraklli V, Holmberg J, Forsberg-Nilsson K, Simon A, Kirkham M. Reprint of: A chemical screen identifies trifluoperazine as an inhibitor of glioblastoma growth. Biochem Biophys Res Commun. 2018 May 5;499(2):136-142. doi: 10.1016/j.bbrc.2018.03.001. Epub 2018 Mar 23. PubMed PMID: 29580626.

纯度：≥98%

CAS：53463-78-8